Metraipolis › archive › dc_366a72cf8ce6

Case Report: squamous transformation after long-term osimertinib in EGFR-mutant lung adenocarcinoma with retained EGFR/TP53 alterations — Europe PMC PMID:42609808

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42609808
DOI
10.3389/fonc.2026.1911851
License (as archived)
solo-consultazione
Archived
2026-10-17T05:13:33.859Z
SHA-256 of the archived text
b796dfdbbb10aeb135ab1ff32ca22de8f30e78046738bdd1401c2449907c3f6e
Stable URL of this page
https://metraipolis.com/documento/dc_366a72cf8ce6

How to cite

Case Report: squamous transformation after long-term osimertinib in EGFR-mutant lung adenocarcinoma with retained EGFR/TP53 alterations — Europe PMC PMID:42609808 — Europe PMC (en), https://europepmc.org/article/MED/42609808 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_366a72cf8ce6 (Metraipolis archive dc_366a72cf8ce6, sha256 b796dfdbbb10aeb135ab1ff32ca22de8f30e78046738bdd1401c2449907c3f6e)
BibTeX
@misc{dc366a72cf8ce6,
  title = {Case Report: squamous transformation after long-term osimertinib in EGFR-mutant lung adenocarcinoma with retained EGFR/TP53 alterations — Europe PMC PMID:42609808},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42609808},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_366a72cf8ce6; sha256 b796dfdbbb10aeb135ab1ff32ca22de8f30e78046738bdd1401c2449907c3f6e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42609808. Agents can read the archived copy with the MCP tool read_document.